LeucotrichiaNCT03402633
Leucotrichia in Vitiligo
An observational study of Leucotrichia, run by Cairo University.
Trial summary
The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Leucotrichia
- What is being tested?
- Examination of leukotrichia in vitiligo patients
- How many people
- 107 participants
- Where
- No sites listed yet
- Study dates
- Apr 2016to Sep 2016
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Vitiligo patients with/ without leukotrichia within the vitiliginous areas presenting to dermatology outpatient clinic at Kasr Alainy Teaching Hospital
Who may be able to join
- Age > 18
- Vitiligo patients with/ without leukotrichia within the vitiliginous areas
Who cannot join
- Age < 18
- Premature hair graying in the trunk before the age of 30
About this study
Official title: Leucotrichia in Vitiligo Patients : A Cross Sectional Study
The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted.
- Conditions
- Leucotrichia
- Being tested
- Examination of leukotrichia in vitiligo patients
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Examination of leukotrichia in vitiligo patientsOther
Examination of leukotrichia will be enhanced by wood's light and dermoscopy for better enhancing of the lesions and good magnification
What is being measured
The primary outcome is the main question the study is designed to answer.
Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients
Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients
Measured: within 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Jan 2018
- Study startApr 2016
- Primary completionSep 2016
- Study completionSep 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for LeucotrichiaStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Cross-sectional
- Enrolment
- 107 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Maha Fathy Elmasry, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03402633
- Sponsor's protocol ID
- Dermatology5
- Status last verified
- Jan 2018
- First submitted
- 11 Jan 2018
- Last updated
- 18 Jan 2018
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 18 Jan 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Leucotrichia in Vitiligo Patients : A Cross Sectional Study
- ClinicalTrials.gov ID
- NCT03402633
- Acronym / sponsor ID
- Dermatology5
- Conditions
- Leucotrichia
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 107 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- Apr 2016 (actual)
- Primary completion
- Sep 2016 (actual)
- Study completion
- Sep 2016 (actual)
- First posted
- 18 Jan 2018 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The incidence of leucotrichia has been reported to range from 9 to 48.4% of all vitiligo patients.Leucotrichia is more often observed in segmental vitiligo with a very high percentage. However, further studies considering the prevalence of leucotrichia in different types of vitiligo need to be conducted.
Study design
- Observational model
- Case only
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Vitiligo patients with/ without leukotrichia within the vitiliginous areas presenting to dermatology outpatient clinic at Kasr Alainy Teaching Hospital
Key inclusion criteria (2 listed)
- Age > 18
- Vitiligo patients with/ without leukotrichia within the vitiliginous areas
Key exclusion criteria (2 listed)
- Age < 18
- Premature hair graying in the trunk before the age of 30
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Examination of leukotrichia in vitiligo patientsExamination of leukotrichia will be enhanced by wood's light and dermoscopy for better enhancing of the lesions and good magnification | Other | – |
Primary outcome
Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients
Time frame: within 6 months
Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 Jan 2018.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Leucotrichia, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 18 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Detection of prevalence of leukotrichia within vitilignous areas in vitiligo patients (time frame: within 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jan 2018.